A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors

NCT06605222 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

201

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: SHR-7787 injection

Sponsor

Shanghai Hengrui Pharmaceutical Co., Ltd.